In Reply
- PMID: 35104071
- DOI: 10.1097/AOG.0000000000004670
In Reply
Conflict of interest statement
Financial Disclosure Alan T. Tita reports money was paid to his institution from the NIH and CDC. The other authors did not report any potential conflicts of interest.
Comment on
-
Evaluation of a Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol.Obstet Gynecol. 2021 Oct 1;138(4):530-538. doi: 10.1097/AOG.0000000000004521. Obstet Gynecol. 2021. PMID: 34623065
-
Evaluation of a Risk-Stratified, Heparin-Based, Obstetric Thromboprophylaxis Protocol.Obstet Gynecol. 2022 Feb 1;139(2):338. doi: 10.1097/AOG.0000000000004667. Obstet Gynecol. 2022. PMID: 35104070 No abstract available.
References
-
- Lu MY, Blanchard CT, Ausbeck EB, Oglesby KR, Page MR, Lazenby AJ, et al. Evaluation of a risk-stratified, heparin-based, obstetric thromboprophylaxis protocol. Obstet Gynecol 2021;138:530–8. doi: 10.1097/aog.0000000000004521 - DOI
-
- Ferres MA, Olivarez SA, Trinh V, Davidson C, Sangi-Haghpeykar H, Aagaard-Tillery KM. Rate of wound complications with enoxaparin use among women at high risk for postpartum thrombosis. Obstet Gynecol 2011;117:119–24 doi: 10.1097/AOG.0b013e3182029180 - DOI
-
- Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med 2005;143:697–706. doi: 10.7326/0003-4819-143-10-200511150-00006 - DOI
-
- Kotaska A. Postpartum heparin thromboprophylaxis: more harm than good. Obstet Gynecol 2021;138:527–9.doi: 10.1097/AOG.0000000000004554 - DOI
Publication types
LinkOut - more resources
Full Text Sources